Table 1.
Fraction | m/z | Ionization mode | Fragmentation (Ms2) | Compounds | References |
---|---|---|---|---|---|
A | 315 | +ve | 297, 283 | Dihydroxy-dimethoxy-isoflavone | (Zhang et al., 2015) |
A | 283 | –ve | 283, 268, 265, 238, 213, 200, 184, 157, 152, 96 | Calycosin | (Ye et al., 2012; Mehmood et al., 2019) |
A | 431 | –ve | 431, 341, 311, 283, 341 | Isovitexin | (Ye et al., 2012) |
B | 325 | –ve | 325, 307, 289, 271, 263, 185, 169 | Naringenin derivative | (Chen et al., 2016) |
B | 431 | –ve | 431, 341, 311, 283, 269 | Vitexin | (Chen et al., 2016) |
B | 339 | –ve | 275, 269, 179, 161, 143 | Caffeoyl-D-glucose | (Shakya and Navarre, 2006) |
C | 311 | –ve | 296, 247 | Cis-cafatric acid | (Lambert et al., 2015) |
C | 137 | –ve | 137, 119, 93 | p-hydroxybenzoic acid | (Arranz et al., 2010) |
(m/z), mass to charge ratio.